CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 51 enrolled
Drug / intervention
INTREPID® Hybrid tipdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05495555
NCT05495555N/ACompleted
CompareCT.gov

The Cutting Efficiency of Hybrid Tips in Different Grades of Cataract

Cataract and Laser Institute of Southern Oregon·observational·Posted Aug 10, 2022·Updated Mar 11, 2025

In Brief

An observational study evaluating INTREPID® Hybrid tip for Cataract. Completed, enrolled 51 participants across 1 site.

Detailed Summary

The objective is to assess the efficiency (as measured by phaco time, aspiration time, and fluid use) of the hybrid tip in removing cataract grade 3 \& 4 in high and low intraocular pressure (IOP) settings.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCataract
CountriesUnited States
CollaboratorsSengi

Timeline

N/ACompletedFinished
2023202420252026
First PostedAug 10, 2022
Enrollment StartAug 3, 2022
Primary CompletionFeb 7, 2024
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 3.9 years ago

Interventions

INTREPID® Hybrid tipdevice

INTREPID® Hybrid tip for cataract removal